Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-09-09
1984-10-09
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544250, 548222, A61K 31505, C07D49804
Patent
active
044761309
ABSTRACT:
3-(1H-tetrazole-5-yl)-4H-pyrimido[2,1-b]-benzoxazol-4-ones are disclosed as anti-allergic compounds. Pharmaceutically acceptable salts, pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
REFERENCES:
patent: 3538086 (1970-11-01), Mair et al.
patent: 3585198 (1971-06-01), Meszaros et al.
patent: 4122274 (1978-10-01), Juby
patent: 4209620 (1980-06-01), Juby
patent: 4223031 (1980-09-01), Covington et al.
Derwent Abstract for Japanese Application 58177991.
Sam and Plampin, J. Pharm. Sci., 53, 538-544, (1964).
Yevich et al., J. Med. Chem., 25, 864-868, published Jul. 1982.
Daus Donald G.
Riker Laboratories Inc.
Rivers Diana G.
Sell Donald M.
Smith James A.
LandOfFree
3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1600048